Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VEGFR-2/DHFR-IN-1 (compound 8b) is a chemical inhibitor targeting VEGFR-2 and DHFR, exhibiting IC50 values of 0.384 μM and 7.881 μM, respectively. It demonstrates effective antibacterial properties against a range of pathogens including Escherichia coli, Streptococcus faecalis, Salmonella enterica, MSSA, and MRSA, with MIC values ranging from 8 to 16 μg/mL. Additionally, this compound shows potent cytotoxic effects against various cancer cell lines such as C26, HepG2, and MCF7, with IC50 values between 2.97 and 7.12 μM, rendering it a valuable tool for cancer research [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 349,000 |
50 mg | 約10-14 週間 | ¥ 454,500 |
100 mg | 約10-14 週間 | ¥ 574,000 |
説明 | VEGFR-2/DHFR-IN-1 (compound 8b) is a chemical inhibitor targeting VEGFR-2 and DHFR, exhibiting IC50 values of 0.384 μM and 7.881 μM, respectively. It demonstrates effective antibacterial properties against a range of pathogens including Escherichia coli, Streptococcus faecalis, Salmonella enterica, MSSA, and MRSA, with MIC values ranging from 8 to 16 μg/mL. Additionally, this compound shows potent cytotoxic effects against various cancer cell lines such as C26, HepG2, and MCF7, with IC50 values between 2.97 and 7.12 μM, rendering it a valuable tool for cancer research [1]. |
In vitro | VEGFR-2/DHFR-IN-1, at concentrations ranging from 2-1024 μg/mL over 18-72 hours, demonstrates significant antimicrobial activity, as evidenced by minimum inhibitory concentration (MIC) values against a variety of pathogens: 16 μg/mL for Escherichia coli, 64 μg/mL for Pseudomonas aeruginosa, 16 μg/mL for Streptococcus faecalis, 16 μg/mL for Salmonella enterica, 8 μg/mL for MSSA, 16 μg/mL for MRSA, 64 μg/mL for Candida albicans, and 256 μg/mL for Aspergillus niger. Additionally, at 0.5-100 μM for 48 hours, it exhibits potent anticancer effects. Its inhibitory action on DHFR and VEGFR-2, identified through concentrations of 0-100 μM over 30 minutes, shows IC50s of 7.881 μM and 0.384 μM, respectively. Furthermore, cell cytotoxicity assays on C26, HepG2, MCF7, and H69PR cell lines, using concentrations between 0.5 and 100 μM over 48 hours, reveal VEGFR-2/DHFR-IN-1's anticancer capabilities, with IC50s of 2.97 μM for C26, 7.12 μM for HepG2, 3.58 μM for MCF7, and 12.79 μM for H69PR cells. |
分子量 | 371.81 |
分子式 | C20H18ClNO4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VEGFR-2/DHFR-IN-1 Inhibitor inhibitor inhibit